Building satisfying meals without strict food rules
Build meals around nourishment, preference and practical preparation, and use satisfaction as information rather than a test of willpower.
Search explainers, questions, and medicine profiles.
The publication’s independent editorial identity, covering weight-management research, treatments and practical strategies. No individual clinician or professional credential is claimed.
How we workMyWeightLab is an independent, evidence-first publication following GLP-1 medicines, obesity-drug research and the practical science of weight management.
This is a publication byline, not a clinician credential. Our articles do not provide diagnosis, prescriptions or individual treatment advice.
We check regulatory documents, trial registries, prescribing information and peer-reviewed research. Trial design, reported results and marketing approval are separate facts. Sponsor announcements are identified as such.
Editorial source review is distinct from independent clinical review. A real reviewer is credited only when their identity and contribution have been verified.
Build meals around nourishment, preference and practical preparation, and use satisfaction as information rather than a test of willpower.
Evaluate a smart scale by separating weight measurement from estimated body composition, then checking validation, usability, costs and privacy.
Build a weight-management plan around sleep opportunities, food access and rotating shifts, with meal-timing evidence kept in its proper context.
What SURMOUNT-5 shows about semaglutide and tirzepatide, and how doses, diabetes status and approved uses limit the comparison.
Learn what a US serving-size label means, scale the figures to your actual portion, and compare foods without treating reference values as personal targets.
Orlistat evidence and limitations: digestive mechanism, XENDOS results, gastrointestinal effects, vitamin absorption and important interactions.
Oral Wegovy in the EU progressed from a May recommendation to a July 2026 Commission decision. Read the current adult label and access limits.
A product-by-product comparison of meal timing, daily versus weekly routines, device needs and the limits of comparing weight-loss results.
Naltrexone-bupropion benefits and restrictions: COR-I evidence, opioid and seizure concerns, blood pressure, mood and EU long-term safety review.
Understand progressive overload as a gradual, reviewable increase in challenge, with technique, goals and recovery guiding the next step.